Breaking News
Get 45% Off 0
🔥 Grab for free: Investing.com’s top 10 stocks for 2025 revealed
Get the List

Zacks Investment Research Zacks Investment Research

Zacks Investment Research's Opinion & Analysis.
Featured here: a complete archive of all posts and research produced by Zacks Investment Research, including current material.
5 Great Reopening Stories to Buy Today By Zacks Investment Research - Sep 13, 2021

While vaccinations continue to support the recovery, the number of infections from the delta variant has shaken people up quite a bit. As a result, investors could be feeling incrementally more...

Value ETFs Looking Attractive Now: Let's Explore By Zacks Investment Research - Sep 13, 2021

The market has started feeling September chills following the subdued Wall Street performance in the month so far. The Dow Jones Industrial Average has lost about 2.2% in its second consecutive...

Why Aflac (AFL) Should be Part of Your Investment Portfolio By Zacks Investment Research - Sep 13, 2021

Aflac Inc. AFL is well poised for growth on the back of regaining its top-line strength and other strategic measures. These include product introductions, expansion of its virtual sales platform,...

Gaming ETFs to Gain Post Apple-Epic Games Ruling By Zacks Investment Research - Sep 13, 2021

Gaming stocks jumped in the Sep 10 trading session, following the Apple AAPL-Epic Games lawsuit ruling. U.S. District Judge Yvonne Gonzalez Rogers (NYSE:ROG) in Oakland, CA ruled that the iPhone maker...

Lockheed (LMT) Wins $101M Deal to Procure Hellfire Missiles By Zacks Investment Research - Sep 12, 2021

Lockheed Martin Corp’s LMT business segment, Missiles and Fire Control, recently secured a modification contract for procuring Hellfire missiles and containers. The U.S. Army Contracting...

Moderna ETFs to Rally on Two-in-One Vaccine Booster Shot News By Zacks Investment Research - Sep 12, 2021

A formidable name among the COVID-19 vaccine developers, Moderna (NASDAQ:MRNA) MRNA, impressed investors with a rally of 7.8% on Sep 9. The shares of the biotechnology company pioneering messenger RNA...

Stocks Stay Red All Week By Zacks Investment Research - Sep 10, 2021

Stocks just finished off this abbreviated week with their worst session in what’s now a five-day losing streak, leaving all of the major indices with sharp declines in just four days as...

Stocks Stay Red All Week By Zacks Investment Research - Sep 10, 2021 1

Stocks just finished off this abbreviated week with their worst session in what’s now a five-day losing streak, leaving all of the major indices with sharp declines in just four days as...

Here's Why Banking ETFs Are Attractive Investment Bets By Zacks Investment Research - Sep 10, 2021

The banking sector is witnessing growing investor attention considering the improving performance of the sector over the past year. The S&P Banks Select Industry Index has surged 62.1% in the past...

Chemours (CC) Stock Up 28% YTD: What's Driving the Rally? By Zacks Investment Research - Sep 10, 2021

The Chemours Company (NYSE:CC)’s CC shares have shot up 27.5% so far this year. The chemical maker has also outperformed its industry’s rise of 7.1% over the same time frame. Moreover, it...

Bull of the Day: Best Buy (BBY) By Zacks Investment Research - Sep 10, 2021

Best Buy (BBY) is a Zacks Rank #1 (Strong Buy) that is a popular electronics retailer. The company specializes in consumer electronics, home office products, entertainment software, communication,...

Delta and the Q3 Earnings Season By Zacks Investment Research - Sep 10, 2021

We all know that the overall earnings picture has been very strong, though the ongoing resurge in Covid infections has started weighing on near-term economic outlook, with estimates of Q3 GDP growth...

Delta and the Q3 Earnings Season By Zacks Investment Research - Sep 10, 2021

We all know that the overall earnings picture has been very strong, though the ongoing resurge in Covid infections has started weighing on near-term economic outlook, with estimates of Q3 GDP growth...

Continue with Apple
Continue with Google
or
Sign up with Email